Leishmaniasis

Leishmaniasis is a disease spread by sandfly bites. It causes sores on the skin, sometimes inside the nose or mouth. It's common in parts of the world like Africa, Asia, and South America.

Condition

What people with Leishmaniasis report

Every report comes from a Lived member, sent anonymously.

Have you tried Amphotericin B for Leishmaniasis?

NameHow it went

About Leishmaniasis

What It Is

Leishmaniasis is an infection caused by Leishmania, a single-celled parasite spread by the bite of infected sand flies. It occurs in parts of the tropics, subtropics and southern Europe, including the Middle East, Central and South America, Africa and Asia. In the United States it is mostly seen in people who have traveled, worked or lived in those regions. The word covers several quite different illnesses, depending on the parasite species and the person's immune response. Cutaneous leishmaniasis, the most common form, causes one or more skin sores, usually where the sand fly bit on exposed skin. Mucosal leishmaniasis, linked mainly to some species found in Latin America, damages the lining of the nose, mouth and throat. Visceral leishmaniasis, also called kala-azar, spreads to the spleen, liver and bone marrow, causing fever, weight loss and low blood counts. Without treatment, visceral leishmaniasis is fatal in most cases, which makes it the form that matters most to recognize.

Causes & Risk Factors

Infection happens when an infected female sand fly bites. Sand flies are small, quiet insects that bite mostly between dusk and dawn. Many people who are bitten and infected never become ill, because the immune system controls the parasite. Illness is more likely in people who have no previous exposure, such as travelers, soldiers and newcomers to an affected area, and in young children, people who are malnourished and people with weakened immunity, including those with HIV. Risk depends heavily on place and activity. Rural and forest work, sleeping outdoors or on the ground, and poor housing raise exposure. There is no approved vaccine, so prevention rests on avoiding bites: staying indoors from dusk to dawn where possible, wearing long sleeves and long pants, using insect repellent and sleeping under bed nets, ideally insecticide-treated ones.

How It's Diagnosed

Because leishmaniasis is uncommon outside affected regions, a diagnosis often starts with the travel history. Mentioning where you have been, even months or years earlier, can be the clue that changes the workup. A skin sore from cutaneous leishmaniasis can look like many other conditions, including bacterial and fungal infections and some skin cancers. For a skin sore, a clinician takes a small sample from the edge or base of the lesion by scraping, needle aspiration or biopsy. A laboratory looks for the parasite under the microscope, may try to grow it, and can use a DNA test called PCR (polymerase chain reaction) to confirm the infection and identify the species. The species matters: it helps predict whether a sore is likely to heal by itself or carries a risk of later nose and mouth involvement, and it guides the choice of treatment. Blood antibody tests are not useful for skin sores. Visceral leishmaniasis looks like other causes of long-lasting fever with an enlarged spleen, such as malaria, tuberculosis, typhoid fever or blood cancers. Testing usually includes blood counts, antibody tests and PCR on blood, and often a sample of bone marrow to look for the parasite directly. People with past skin disease from Latin America are usually examined inside the nose and mouth even without symptoms.

Treatment Options

Treatment depends on the form of disease, the species, where the infection was acquired, how many sores there are and where, and the person's overall health. For this reason, care is often guided by an infectious disease or travel medicine specialist. Many skin sores caused by species from the Middle East, Mediterranean, Africa and Asia heal on their own over months, so a small, mild sore may sometimes be watched rather than treated. When a few sores need treatment, local options act directly on the lesion: freezing with liquid nitrogen (cryotherapy), controlled heat, or injections of an antimony medicine into the sore. These avoid whole-body side effects but can be painful. Medicine taken by mouth or given by injection or infusion is considered for many sores, sores on the face or in places that are hard to treat locally, and infections from Latin American species that can later spread to the nose and mouth. The main whole-body medicines are older antimony compounds (sodium stibogluconate and meglumine antimoniate), given by injection for several weeks with significant side effects that need regular blood tests and heart monitoring; liposomal amphotericin B (AmBisome), an intravenous antiparasitic and antifungal medicine that is a standard treatment for visceral leishmaniasis in the United States; and miltefosine (Impavido), the only oral option, taken as capsules for about four weeks. Miltefosine often causes nausea, vomiting or diarrhea, and it can harm a developing baby, so it is not used during pregnancy. Women who could become pregnant need a pregnancy test first and effective contraception during treatment and for five months afterward. No single drug works equally well for every species or region, and evidence for many skin treatments is limited, so the choice involves weighing likely benefit against side effects and practicality. Visceral leishmaniasis always needs prompt, complete treatment. In people with HIV or other immune suppression, the disease is more severe and relapse is more common; treating HIV itself lowers that risk, and these patients need closer follow-up.

What to Expect

Cutaneous leishmaniasis usually begins weeks to months after the bite as a small bump that slowly enlarges and often opens into an ulcer that may crust over. Even when sores heal on their own, healing can take months to years and often leaves a permanent scar, which can matter a great deal on the face. Treatment aims to clear the infection and limit damage, and follow-up visits over the following months check that sores keep healing and do not return. For infections acquired in parts of Latin America, especially from Leishmania braziliensis, the parasite can later reach the nose and mouth, most often within the first two years but sometimes later. Whole-body treatment of the original skin infection lowers this risk considerably but does not remove it entirely, so long-term awareness matters. Visceral leishmaniasis is curable, and with timely treatment most people recover. Follow-up checks over the next several months look for relapse. In South Asia and East Africa, some people develop a rash called post-kala-azar dermal leishmaniasis months to years after apparent cure. Because the parasite is not always fully cleared, serious immune suppression later in life, such as from HIV, chemotherapy or transplant medicines, can allow the infection to return, which is worth telling future clinicians about.

When to Seek Help

See a clinician if a skin sore that started after time in an affected region has not healed within a few weeks, and mention your travel history. Seek medical care promptly, within a day or so, if fever lasting more than a week or two, unexplained weight loss, or swelling or fullness in the upper left belly develops after living in or traveling to an area where visceral leishmaniasis occurs. If you have ever had skin leishmaniasis acquired in Latin America, arrange an evaluation for a persistently stuffy or bleeding nose, nasal discharge, or sores in the nose or mouth, even years later. During treatment, contact your care team promptly about persistent vomiting or diarrhea, signs of dehydration, or a possible pregnancy while taking miltefosine.

Questions to Ask Your Doctor

  1. 1.Which species of Leishmania is causing this, and how does that change the treatment you recommend?
  2. 2.Is this sore likely to heal on its own, and what are the trade-offs between watching it, local treatment and medicine for the whole body?
  3. 3.What side effects should I expect from this treatment, and what monitoring will I need while I take it?
  4. 4.How will we know the infection is cured, and how long should follow-up continue?
  5. 5.Is there any risk of this spreading to my nose or mouth, or coming back if my immune system is weakened later?

Last reviewed • Oct 2026

Educational content, not medical advice.